- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 5/0781 - B cells; Progenitors thereof
Patent holdings for IPC class C12N 5/0781
Total number of patents in this class: 626
10-year publication summary
33
|
34
|
39
|
65
|
77
|
55
|
57
|
69
|
54
|
19
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Immusoft Corporation | 22 |
15 |
Hoffmann-La Roche Inc. | 3060 |
14 |
Duke University | 2872 |
14 |
Dana-Farber Cancer Institute, Inc. | 2455 |
13 |
F. Hoffmann-La Roche AG | 7958 |
11 |
The Invention Science Fund II, LLC | 46 |
11 |
Kling Biotherapeutics B.V. | 32 |
11 |
Crystal Bioscience Inc. | 81 |
10 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
10 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
9 |
The Regents of the University of California | 18943 |
8 |
President and Fellows of Harvard College | 5792 |
8 |
Kaneka Corporation | 4445 |
8 |
Sanofi Pasteur VaxDesign Corporation | 50 |
8 |
Centre National de La Recherche Scientifique | 9632 |
7 |
Institute for Research in Biomedicine | 95 |
7 |
Iovance Biotherapeutics, Inc. | 301 |
7 |
The Johns Hopkins University | 5377 |
6 |
Ohio State Innovation Foundation | 1770 |
6 |
Tokyo University of Science Foundation | 343 |
6 |
Other owners | 437 |